Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Ark Therapeutics Group plc    AKT   GB0034251727

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Business Summary
Logo Ark Therapeutics Group plc
Discovers and develops medicinal gene-based and biological therapies and diagnostic products

Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer.

The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.
Sales per Businesses
2012
GBP (in Million)%
Research and Devlopment1.82100%
Sales per Regions
20122013Delta
GBP (in Million)%GBP (in Million)%
United Kingdom1.3473.7%---
Rest of Europe0.47025.9%---
United States0.0080.4%---
Finland-----
-----
Managers
NameAgeSinceTitle
Iain Gladstone Ross602010Non-Executive Chairman
Robert Shaw-2005Technical Director
Sue Steven--Secretary & Non-Executive Director
David C. Venables, PhD-2012Non-Executive Director
Shareholders
NameShares%
J.O. Hambro Capital Management Ltd. 20,659,4509.87%
Brewin Dolphin Ltd. 16,584,5407.92%
Hargreaves Lansdown Stockbrokers Ltd. 15,266,0007.29%
Smith & Williamson Investment Management LLP 14,816,1577.08%
Standard Life Investments Ltd. 14,654,2837.00%
Barclays Bank Plc (Private Banking) 14,473,9606.92%
Hargreaves Lansdown Asset Management Ltd. 12,685,0316.06%
TD Direct Investing (Europe) Ltd. 11,962,6685.72%
Midas Investment Management Ltd. 9,528,1374.55%
Peel Hunt LLP (Market-Maker) 8,261,0003.95%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality
Business Predictability -
PER -
Potential -
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
OTSUKA HOLDINGS C..
ASPEN PHARMACARE ..
BIOMARIN PHARMACE..
ONO PHARMACEUTICA..
ENDO INTERNATIONA..
HOSPIRA, INC.
CIPLA LTD
SIHUAN PHARMACEUT..
SHANGHAI FOSUN PH..
TAISHO PHARMACEUT..
LUYE PHARMA GROUP..
-
CADILA HEALTHCARE..
CHINA MEDICAL SYS..
DIVI'S LABORATORI..
XIZANG HAISCO PHA..
SHENZHEN SALUBRIS..
SICHUAN KELUN PHA..
-
SHENZHEN HEPALINK..
-
GLENMARK PHARMACE..
Sector Pharmaceuticals
Company contact information
Ark Therapeutics Group Plc
85 Tottenham Court Road
London, London & South East W1T 4TQ

Phone : +44.20.7002.1005
Fax : +44.20.7268.3100
Web : www.arktherapeutics.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF